skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive

Review

(2370) Views  (682) Full article downloads

Authors: Heather Hohmann

Published Date July 2009 Volume 2009:3 Pages 205 - 211
DOI: http://dx.doi.org/10.2147/PPA.S4299

Heather Hohmann

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Abstract: Contraceptive implants provide long-acting, highly effective reversible contraception. The etonogestrel implant (ENG implant) is a single rod implant that offers three years of efficacy. The ENG implant was designed to provide contraceptive efficacy by inhibiting ovulation and Pearl Index scores reported for this method are similar to other long-acting reversible contraception as well as similar to sterilization. The implant has been shown to be safe during breast feeding and may improve symptoms of dysmenorrhea and endometriosis. Irregular bleeding patterns can be expected with the device’s use and should be addressed in order to decrease rates of discontinuation.

Keywords: contraception, Implanon®, progestin-only, ENG-implant








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Drospirenone/ethinyl estradiol 3 mg/20 µg (24/4 day regimen): hormonal contraceptive choices – use of a fourth-generation progestin
Distribution and determinants of patient satisfaction in oncology: A review of the literature
Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy
Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
Failure of Implanon® on antituberculous therapy
Users’ perspectives on Implanon in Malaysia, a multicultural Asian country
Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery